The BRICS IoT implantable cardiac devices market size is expected to reach US$ 11,970.6 million by 2033 from US$ 2,762.0 million in 2024. The market is estimated to record a CAGR of 17.7% from 2025 to 2033.
Executive Summary and BRICS IoT Implantable Cardiac Devices Market Analysis:
The IoT implantable cardiac devices market in BRICS is experiencing significant growth driven by the rising incidence of cardiovascular diseases & arrhythmias, demand for real-time monitoring & early intervention, advancements in device miniaturization & battery life. The IoT implantable cardiac devices market in BRICS reflects the variety and extent of these major economies. These countries together face an increasing prevalence of cardiovascular diseases, which is the result of aging populations, urbanization, and lifestyle changes. Connected pacemakers hold the largest share in the product market, as the demand for rhythm management solutions is increasing. Bluetooth-enabled devices are at the forefront of the technology segment because of their low cost and compatibility with smartphones, which are widely used in BRICS countries. Hospitals and clinics are still the major end-users as they can provide the necessary infrastructure and expertise for implantation and monitoring. The multinational players like Medtronic, Abbott, and Philips are widening their footprints through partnerships with local distributors, while domestic innovators in India, China, and Brazil are coming up with low-cost IoT-enabled solutions customized to meet local needs. The market assessment reveals that BRICS is shifting from traditional cardiac care towards IoT-enabled solutions; thus, the region becomes a vital growth catalyst for worldwide implantable cardiac technologies.
Key segments that contributed to the derivation of the IoT implantable cardiac devices market analysis are product, technology, application, and end user.
By product, the IoT implantable cardiac devices market is segmented into IoT connected pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, cardiac resynchronization therapy devices, and others. IoT connected pacemakers dominated the market in 2024, driven by the rising cardiovascular disease burden across populous BRICS nations.
By technology, the IoT implantable cardiac devices market is segmented into Bluetooth, cellular, and others. Bluetooth dominated the market in 2024, driven by affordability and compatibility with smartphones widely adopted in BRICS economies.
In terms of application, the market is segmented into arrhythmia detection, heart failure monitoring, remote pacemaker management, and others. Arrhythmia detection dominated the market in 2024, driven by the increasing need for continuous monitoring in high‑risk populations.
By end user, the market is segmented into hospitals & clinics, specialty cardiac centers, and others. Hospitals & clinics dominated the market in 2024, driven by reliance on tertiary care centers for advanced cardiac procedures.
BRICS IoT Implantable Cardiac Devices Market Outlook
The BRICS IoT Implantable Cardiac Devices market outlook is characterized by the potential for robust growth that is largely supported by improvements in infrastructure and the adoption of digital health. In these upcoming years, government-supported healthcare reforms, extension of the telecom networks, and the demand for remote monitoring will be the main factors to convince people to adopt these devices. Even if Bluetooth-enabled pacemakers will still be the major product, it is highly probable that cellular-enabled devices, in particular, will be able to get a handful of users as 5G infrastructures become more common in China, India, and Russia. Affordability will be the main factor of strategic investments with regard to the healthcare sector by the use of modular device designs and subscription-based monitoring services, which will be customized for different healthcare systems. The training of healthcare professionals will also be very important to provide the correct implantation and monitoring of the devices. In fact, urban areas like Sao Paulo, Moscow, Mumbai, Beijing, and Johannesburg will be the main drivers of demand. Also, the outlook emphasizes manufacturing hubs of the region, like China and India, which will be able to make products at lower prices and offer them to more people. At large, the BRICS evolution is leading to a scenario where the market will be mainly characterized by affordability, innovation, and local strategies that are in line with different healthcare landscapes.
BRICS IoT Implantable Cardiac Devices Market Country Insights
Based on country, the BRICS IoT implantable cardiac devices market is segmented into Russia, Brazil, South Africa, India, China, Egypt, Indonesia, Saudi Arabia, and the UAE. China held the largest share in 2024.
Insights at the country level show different adoption patterns across the BRICS countries. China is a leader with massive investments in healthcare infrastructure and strong government support for digital health initiatives. India is a high-potential market; a large population will drive the demand owing to the increasing cardiovascular disease burden; however, affordability and access are still problems. Brazil is focused on telehealth expansion, which is creating demand for IoT-enabled cardiac devices in both urban and rural areas. Russia is slowly embracing IoT-enabled devices, and the healthcare modernization programs backed by the government are helping in this regard. South Africa, with its well-developed private healthcare sector, is expecting increased use of implantable monitors and pacemakers. Local partnerships are very important, as multinational players collaborate with regional distributors and healthcare providers to deal with regulatory complexities and ensure supply chain efficiency. Together, the BRICS countries portray a combination of opportunities, with mature markets setting the benchmarks and emerging ones offering the growth potential. The region's success will depend on making strategies according to local situations, balancing affordability with innovation, and exploiting partnerships to bridge the gaps in infrastructure and expertise.
BRICS IoT Implantable Cardiac Devices Market Company Profiles
Medtronic Plc, GE HealthCare Technologies Inc, Koninklijke Philips NV, Abbott Laboratories, Boston Scientific Corporation, Johnson & Johnson, Biotronik, MicroPort Scientific Corporation, LivaNova PLC, LEPU Medical Technology (Beijing) Co., Ltd., are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
BRICS IoT Implantable Cardiac Devices Market Research Methodology:
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites, annual reports, financial statements, broker analyses, and investor presentations
Industry trade journals and other relevant publications
Government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
Primary Research
Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
Refine findings from secondary research
Enhance the expertise and market understanding of the analysis team
Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
BRICS IoT Implantable Cardiac Devices Market Country and Regional Insights
The List of Companies - BRICS IoT Implantable Cardiac Devices Market
Medtronic Plc
GE HealthCare Technologies Inc
Koninklijke Philips NV
Abbott Laboratories
Boston Scientific Corporation
Johnson & Johnson
Biotronik
MicroPort Scientific Corporation
LivaNova PLC
LEPU Medical Technology (Beijing) Co., Ltd.
Frequently Asked Questions
How big is the BRICS IoT Implantable Cardiac Devices Market?
The BRICS IoT Implantable Cardiac Devices Market is valued at US$ 2,762.0 Million in 2024, it is projected to reach US$ 11,970.6 Million by 2033.
What is the CAGR for BRICS IoT Implantable Cardiac Devices Market by (2025 - 2033)?
As per our report BRICS IoT Implantable Cardiac Devices Market, the market size is valued at US$ 2,762.0 Million in 2024, projecting it to reach US$ 11,970.6 Million by 2033. This translates to a CAGR of approximately 17.7% during the forecast period.
What segments are covered in this report?
The BRICS IoT Implantable Cardiac Devices Market report typically cover these key segments-
End User (Hospitals & Clinics, Specialty Cardiac Centers, Others)
What is the historic period, base year, and forecast period taken for BRICS IoT Implantable Cardiac Devices Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the BRICS IoT Implantable Cardiac Devices Market report:
Historic Period : 2022-2023
Base Year : 2024
Forecast Period : 2025-2033
Who are the major players in BRICS IoT Implantable Cardiac Devices Market?
The BRICS IoT Implantable Cardiac Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Medtronic Plc
GE HealthCare Technologies Inc
Koninklijke Philips NV
Abbott Laboratories
Boston Scientific Corporation
Johnson & Johnson
Biotronik
MicroPort Scientific Corporation
LivaNova PLC
LEPU Medical Technology (Beijing) Co., Ltd.
Who should buy this report?
The BRICS IoT Implantable Cardiac Devices Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the BRICS IoT Implantable Cardiac Devices Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For BRICS IoT Implantable Cardiac Devices Market
